An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

Not Applicable

Completed

• Conditions: Ocular Hypertension
• Interventions: Drug: C-KAD Ophthalmic Solution

• Registration Number: NCT00825396
• Lead Sponsor: Chakshu Research, Inc.

Brief Summary

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04
• Study First Submitted: 2009-01-16
• Study First Submitted QC: 2009-01-16
• Study First Posted: 2009-01-21
• Primary Completion: 2009-04
• Study Completion: 2009-04
• Status Verified: 2009-06
• Last Update Submitted: 2009-06-09
• Last Update Posted: 2009-06-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
• Both eyes having best corrected visual acuity better than 20/50

Exclusion Criteria

• Advanced glaucoma
• Closed or barely open anterior chamber or history of angle closure

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
C-KAD Ophthalmic Solution	C-KAD Ophthalmic Solution	-

Primary Outcome Measures

Name	Time	Method
Mean change in intraocular pressure from baseline	150 Days

Trial Locations

Locations (1)

Charlotte Eye, Ear, Nose & Throat Associates; 🇺🇸 Charlotte, North Carolina, United States